References
- Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-1291. https://doi.org/10.1056/NEJM199910213411707
- Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007;48:573-585. https://doi.org/10.3349/ymj.2007.48.4.573
- Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behcet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999;38:728-733. https://doi.org/10.1093/rheumatology/38.8.728
- Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford) 2004;43:73-78. https://doi.org/10.1093/rheumatology/keg453
- International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-1080.
- Chang HK, Kim SY. Survey and validation of the criteria for Behcet's disease recently used in Korea: a suggestion for modification of the International Study Group criteria. J Korean Med Sci 2003;18:88-92. https://doi.org/10.3346/jkms.2003.18.1.88
- Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-3191. https://doi.org/10.1097/00007632-200012150-00014
- Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432. https://doi.org/10.1016/0895-4356(93)90142-N
- Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behcet's disease. J Rheumatol 2004;31:931-937.
- Touma Z, Ghandour L, Sibai A, et al. Cross-cultural adaptation and validation of Behcet's disease quality of life questionnaire. BMC Med Res Methodol 2011;11:52. https://doi.org/10.1186/1471-2288-11-52
- Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES. The Behcet's Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J 2008;49:698-704. https://doi.org/10.3349/ymj.2008.49.5.698
- Hamuryudan V, Fresko I, Direskeneli H, et al. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology (Oxford) 1999;38:734-736. https://doi.org/10.1093/rheumatology/38.8.734
- Neves FS, Moraes JC, Kowalski SC, Goldenstein-Sc hainberg C, Lage LV, Goncalves CR. Cross-cultural adaptation of the Behcet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 2007;26:1263-1267. https://doi.org/10.1007/s10067-006-0484-y
Cited by
- Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea vol.31, pp.1, 2015, https://doi.org/10.3904/kjim.2016.31.1.170
- Behçet's Disease Current Activity Form as a Patient's Derived Measure vol.23, pp.1, 2016, https://doi.org/10.4078/jrd.2016.23.1.19
- CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet’s disease vol.7, pp.None, 2017, https://doi.org/10.1038/s41598-017-15189-9
- Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes vol.10, pp.None, 2015, https://doi.org/10.2147/prom.s163601
- Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.769785
- Integrative Medicine (Herbal Medicine Combined with Drug Therapy) for Behcet’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials vol.13, pp.4, 2015, https://doi.org/10.3390/pharmaceutics13040476